论文部分内容阅读
目的:分析腺苷蛋氨酸治疗慢性重型肝炎疾病临床结果。方法:抽选2012年9月-2014年10月,我院接收慢性重型肝炎患者60例,按入院编号分成两组(观察组、对照组各30例),对照组患者行临床基础性治疗,观察组患者在基础疗法上加用腺苷蛋氨酸药物治疗,比较分析2组治疗结果。结果:观察组患者临床疾病治疗好转率(96.7%)、并发症总率(3.3%)和对照组(好转率76.7%、并发症总率20.0%)相比,差异具有统计学意义(P<0.05)。结论:腺苷蛋氨酸治疗慢性重型肝炎患者效果显著。
Objective: To analyze the clinical results of adenosine methionine in the treatment of chronic severe hepatitis. Methods: From September 2012 to October 2014, 60 cases of patients with chronic severe hepatitis were admitted to our hospital, divided into two groups according to admission numbers (observation group and control group, 30 cases each). Patients in the control group underwent basic clinical treatment, Patients in the observation group were treated with adenosine methionine on the basis of therapy, and the results of the two groups were compared. Results: The improvement rates of clinical disease treatment (96.7%), total complication rate (3.3%) and control group (76.7% improvement rate and 20.0% complication rate) in the observation group were significantly different (P < 0.05). Conclusion: Adenosine methionine treatment of patients with chronic severe hepatitis has a significant effect.